ArticleResearch (Washington, D.C.)2021

Responsive Dual-Targeting Exosome as a Drug Carrier for Combination Cancer Immunotherapy.

Yuanyuan Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.